These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30058787)

  • 21. The effects of intravenous fosaprepitant and ondansetron in the prevention of postoperative nausea and vomiting in patients who underwent lower limb surgery: a prospective, randomized, double-blind study.
    Kakuta N; Kume K; Hamaguchi E; Tsutsumi R; Mita N; Tanaka K; Tsutsumi YM
    J Anesth; 2015 Dec; 29(6):836-41. PubMed ID: 26210166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A risk adapted approach reduces the overall institutional incidence of postoperative nausea and vomiting.
    Biedler A; Wermelt J; Kunitz O; Müller A; Wilhelm W; Dethling J; Apfel CC
    Can J Anaesth; 2004 Jan; 51(1):13-9. PubMed ID: 14709454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
    de Leon J; Susce MT; Murray-Carmichael E
    Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of 5-HT3B Receptor Gene Polymorphisms with the Efficacy of Ondansetron for Postoperative Nausea and Vomiting.
    Kim MS; Lee JR; Choi EM; Kim EH; Choi SH
    Yonsei Med J; 2015 Sep; 56(5):1415-20. PubMed ID: 26256989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fosaprepitant versus ondansetron for the prevention of postoperative nausea and vomiting in patients who undergo gynecologic abdominal surgery with patient-controlled epidural analgesia: a prospective, randomized, double-blind study.
    Soga T; Kume K; Kakuta N; Hamaguchi E; Tsutsumi R; Kawanishi R; Fukuta K; Tanaka K; Tsutsumi YM
    J Anesth; 2015 Oct; 29(5):696-701. PubMed ID: 25801542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.
    Singh PM; Borle A; Gouda D; Makkar JK; Arora MK; Trikha A; Sinha A; Goudra B
    J Clin Anesth; 2016 Nov; 34():459-82. PubMed ID: 27687434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ondansetron in the prophylaxis of postoperative nausea and vomiting in ambulatory cataract surgery].
    Arregui LM; Leonato MS; Vigil MD; Pérez de Cossío JM; Cardona A; Martínez de la Casa JM
    Rev Esp Anestesiol Reanim; 1999 Apr; 46(4):139-42. PubMed ID: 10365609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventing Postoperative Nausea and Vomiting During an Ondansetron Shortage.
    Moore CC; Bledsoe LTR; Bonds CR; Keller M; King CH
    AANA J; 2021 Apr; 89(2):161-167. PubMed ID: 33832577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery.
    Kim SI; Kim SC; Baek YH; Ok SY; Kim SH
    Br J Anaesth; 2009 Oct; 103(4):549-53. PubMed ID: 19700442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of P6 acupressure with sea-band in reducing postoperative nausea and vomiting in patients undergoing craniotomy: a randomized, double-blinded, placebo-controlled study.
    Nilsson I; Karlsson A; Lindgren L; Bergenheim T; Koskinen LO; Nilsson U
    J Neurosurg Anesthesiol; 2015 Jan; 27(1):42-50. PubMed ID: 24978062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiemetic prophylaxis for office-based surgery: are the 5-HT3 receptor antagonists beneficial?
    Tang J; Chen X; White PF; Wender RH; Ma H; Sloninsky A; Naruse R; Kariger R; Webb T; Zaentz A
    Anesthesiology; 2003 Feb; 98(2):293-8. PubMed ID: 12552184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.
    Sachse C; Brockmöller J; Bauer S; Roots I
    Am J Hum Genet; 1997 Feb; 60(2):284-95. PubMed ID: 9012401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effectiveness of metoclopramide, ondansetron, and granisetron on the prevention of nausea and vomiting after laparoscopic cholecystectomy.
    Oksuz H; Zencirci B; Ezberci M
    J Laparoendosc Adv Surg Tech A; 2007 Dec; 17(6):803-8. PubMed ID: 18158814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of dexamethasone and ondansetron for prophylaxis of postoperative nausea and vomiting in laparoscopic gynecologic surgery.
    D'souza N; Swami M; Bhagwat S
    Int J Gynaecol Obstet; 2011 May; 113(2):124-7. PubMed ID: 21392762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
    Dorado P; Cáceres MC; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
    Biotechniques; 2005 Oct; 39(4):571-4. PubMed ID: 16235570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of acustimulation (ReliefBand) versus ondansetron (Zofran) in combination with droperidol for preventing nausea and vomiting.
    White PF; Issioui T; Hu J; Jones SB; Coleman JE; Waddle JP; Markowitz SD; Coloma M; Macaluso AR; Ing CH
    Anesthesiology; 2002 Nov; 97(5):1075-81. PubMed ID: 12411789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of vestipitant with ondansetron for the treatment of breakthrough postoperative nausea and vomiting after failed prophylaxis with ondansetron.
    Kranke P; Thompson JP; Dalby PL; Eberhart LH; Novikova E; Johnson BM; Russ SF; Noble R; Brigandi RA
    Br J Anaesth; 2015 Mar; 114(3):423-9. PubMed ID: 25488303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study.
    Fux R; Mörike K; Pröhmer AM; Delabar U; Schwab M; Schaeffeler E; Lorenz G; Gleiter CH; Eichelbaum M; Kivistö KT
    Clin Pharmacol Ther; 2005 Oct; 78(4):378-87. PubMed ID: 16198657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Aprepitant in Prevention of Postoperative Nausea and Vomiting After Bariatric Surgery.
    Therneau IW; Martin EE; Sprung J; Kellogg TA; Schroeder DR; Weingarten TN
    Obes Surg; 2018 Jan; 28(1):37-43. PubMed ID: 28674839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylaxis of postoperative nausea and vomiting with ondansetron, metoclopramide, or placebo in total intravenous anesthesia patients undergoing laparoscopic cholecystectomy.
    Kaki AM; Abd El-Hakeem EE
    Saudi Med J; 2008 Oct; 29(10):1408-13. PubMed ID: 18946563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.